AVOMay 22, 2026 at 8:10 PM UTCFood, Beverage & Tobacco

Mission Produce-CalaVo Merger Clears Mexican Antitrust Hurdle, Closing Set for May 28

Read source article

What happened

Mission Produce announced on May 22, 2026 that its merger with Calavo Growers has received approval from Mexican antitrust authorities, with closing expected on May 28, 2026, subject to remaining conditions. This removes a significant regulatory overhang in the largest avocado sourcing region, increasing the probability that the deal closes on time and delivers the targeted $25 million in annualized cost synergies. The news supports the bull case scenario outlined in the DeepValue master report, which assigned a 20% probability and $18 implied value, as network consolidation and SG&A cuts become more tangible. However, investors should remain cautious: the merger still requires other closing conditions, and integration execution risks persist, particularly given Calavo's recent regulatory and tariff missteps. The stock has already appreciated in anticipation of this milestone, and at $13.17, it trades near the midpoint of the master report's $11 attractive entry and $16 trim above levels, offering limited near-term upside without further catalysts.

Implication

For investors, this news increases the probability that the Calavo merger closes on schedule, which could unlock the $25 million synergy target and improve EBITDA margins toward the 9% bull case. The master report's WAIT rating with a $11 attractive entry remains prudent, as the stock at $13.17 already embeds the closing likelihood and offers a modest 8-9% upside to the base case $15 value. Near-term catalysts to watch include the remaining closing conditions, initial integration results, and any tariff or trade policy developments that could pressure margins. Investors with a longer horizon may consider building positions on pullbacks toward $11-12, which would provide a better margin of safety given the ongoing integration risks and high customer concentration. The thesis delta is that the regulatory clearance removes a key downside risk, shifting the probability weight from the bear case toward the base and bull cases, but the valuation still argues for patience rather than aggressive accumulation.

Thesis delta

The Mexican antitrust approval materially increases the likelihood of a timely close, shifting our scenario probabilities slightly toward the bull case. However, the stock's current price discounts this progress, so the WAIT rating with an attractive entry of $11 remains appropriate; we would look to add on any post-close profit-taking or broader market weakness.

Confidence

high